Chunxia Liu

721 total citations
30 papers, 597 citations indexed

About

Chunxia Liu is a scholar working on Molecular Biology, Organic Chemistry and Physiology. According to data from OpenAlex, Chunxia Liu has authored 30 papers receiving a total of 597 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 9 papers in Organic Chemistry and 4 papers in Physiology. Recurrent topics in Chunxia Liu's work include Asymmetric Synthesis and Catalysis (7 papers), Asymmetric Hydrogenation and Catalysis (4 papers) and Receptor Mechanisms and Signaling (3 papers). Chunxia Liu is often cited by papers focused on Asymmetric Synthesis and Catalysis (7 papers), Asymmetric Hydrogenation and Catalysis (4 papers) and Receptor Mechanisms and Signaling (3 papers). Chunxia Liu collaborates with scholars based in China, Hong Kong and Portugal. Chunxia Liu's co-authors include Liang Hong, Wangsheng Sun, Rui Wang, Lei Wang, Depeng Zhao, Hai Qian, Wenlong Huang, Kwok‐Yin Wong, Yuxuan Dai and Siyi Wu and has published in prestigious journals such as Chemical Communications, Chemistry - A European Journal and Organic Letters.

In The Last Decade

Chunxia Liu

27 papers receiving 593 citations

Peers

Chunxia Liu
David J. St. Jean United States
James C. Lanter United States
Hong-Yong Kim South Korea
Kevin J. Filipski United States
Thomas J. Rayl United States
Chunxia Liu
Citations per year, relative to Chunxia Liu Chunxia Liu (= 1×) peers Kenneth L. Granberg

Countries citing papers authored by Chunxia Liu

Since Specialization
Citations

This map shows the geographic impact of Chunxia Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chunxia Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chunxia Liu more than expected).

Fields of papers citing papers by Chunxia Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chunxia Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chunxia Liu. The network helps show where Chunxia Liu may publish in the future.

Co-authorship network of co-authors of Chunxia Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Chunxia Liu. A scholar is included among the top collaborators of Chunxia Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chunxia Liu. Chunxia Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Chunxia, Wenxin Wang, Haoyang Chen, et al.. (2025). Structure optimization of natural product piperine to obtain novel and potent analogs with anti-inflammation pain and urate-lowering effect. European Journal of Medicinal Chemistry. 292. 117649–117649.
2.
Liu, Chunxia, Ning Wang, Lei Zhao, et al.. (2025). Design, synthesis, and biological evaluation of 2, 6-di-substituted indole derivatives as METTL3 inhibitors. European Journal of Medicinal Chemistry. 300. 118134–118134.
3.
Liu, Chunxia, Ling Li, Xiangbo Meng, et al.. (2025). Sophoraflavanone G as an ectosteric inhibitor of cathepsin K attenuates ovariectomy-induced bone loss by suppressing bone resorption. Phytomedicine. 141. 156720–156720. 2 indexed citations
4.
Liu, Chunxia, Wenxin Wang, Shiyu Zhao, et al.. (2024). Discovery of first-in-class highly selective TRPV1 antagonists with dual analgesic and hypoglycemic effects. Bioorganic & Medicinal Chemistry. 107. 117750–117750. 5 indexed citations
5.
Liu, Chunxia, et al.. (2022). Downregulation of SIRT3 Aggravates Lung Ischemia Reperfusion Injury by Increasing Mitochondrial Fission and Oxidative Stress through HIF‐1α‐Dependent Mechanisms. Oxidative Medicine and Cellular Longevity. 2022(1). 9041914–9041914. 16 indexed citations
6.
Yang, Wenxiang, et al.. (2022). Study on Chronic Toxicity of Rhubarb Extract in Sprague-Dawley Rats. SSRN Electronic Journal.
7.
Wu, Siyi, Li Zhao, Chunxia Liu, et al.. (2021). VX765, a Specific Caspase‐1 Inhibitor, Alleviates Lung Ischemia Reperfusion Injury by Suppressing Endothelial Pyroptosis and Barrier Dysfunction. BioMed Research International. 2021(1). 4525988–4525988. 24 indexed citations
8.
Liu, Hao, Chunxia Liu, Siyi Wu, et al.. (2021). [Role and regulatory mechanism of triggering receptor expressed on myeloid cells 2 in mice lung ischemia/reperfusion injury].. 33(8). 933–937. 4 indexed citations
9.
Ye, Zhiwen, Chunxia Liu, Feng Zou, et al.. (2020). Discovery of novel potent GPR40 agonists containing imidazo[1,2-a]pyridine core as antidiabetic agents. Bioorganic & Medicinal Chemistry. 28(13). 115574–115574. 18 indexed citations
10.
Liu, Chunxia, Qingbo Liu, Kun Dong, et al.. (2020). Theoretically obtained insight into the effect of basic amino acids on Cypridina bioluminescence. Journal of Photochemistry and Photobiology A Chemistry. 406. 113000–113000. 4 indexed citations
11.
Wang, Tiantian, Chunxia Liu, Linghui Pan, et al.. (2020). Inhibition of p38 MAPK Mitigates Lung Ischemia Reperfusion Injury by Reducing Blood–Air Barrier Hyperpermeability. Frontiers in Pharmacology. 11. 569251–569251. 27 indexed citations
12.
Dai, Yuxuan, Chunxia Liu, Qifei Li, et al.. (2019). Development of cell-permeable peptide-based PROTACs targeting estrogen receptor α. European Journal of Medicinal Chemistry. 187. 111967–111967. 29 indexed citations
13.
Liu, Yan, Chen Liao, Jiaqi Zhou, et al.. (2018). Novel benzodiazepines derivatives as analgesic modulating for Transient receptor potential vanilloid 1. Bioorganic & Medicinal Chemistry. 26(15). 4567–4573. 13 indexed citations
14.
Liu, Chunxia, Xue Xu, Qianqian Qiu, et al.. (2017). Discovery of phenylsulfonyl acetic acid derivatives with improved efficacy and safety as potent free fatty acid receptor 1 agonists for the treatment of type 2 diabetes. European Journal of Medicinal Chemistry. 138. 458–479. 29 indexed citations
15.
Li, Zheng, Chunxia Liu, Wei Shi, et al.. (2017). Identification of highly potent and orally available free fatty acid receptor 1 agonists bearing isoxazole scaffold. Bioorganic & Medicinal Chemistry. 26(3). 703–711. 15 indexed citations
16.
Li, Guocheng, et al.. (2010). Determination of Naphazoline Hydrochloride and Chlorphenamine Maleateide in rhinitis nasal drops by HPLC. Guoji yiyao weisheng daobao. 16(2). 192–196. 1 indexed citations
17.
Hong, Liang, Wangsheng Sun, Chunxia Liu, Depeng Zhao, & Rui Wang. (2010). Enantioselective construction of allylic phosphine oxides through substitution of Morita–Baylis–Hillman carbonates with phosphine oxides. Chemical Communications. 46(16). 2856–2856. 87 indexed citations
18.
Hong, Liang, Wangsheng Sun, Chunxia Liu, et al.. (2009). Enantioselective Friedel–Crafts Alkylation of 4,7‐Dihydroindoles with Enones Catalyzed by Primary–Secondary Diamines. Chemistry - A European Journal. 15(42). 11105–11108. 61 indexed citations
19.
Hong, Liang, Wangsheng Sun, Chunxia Liu, Lei Wang, & Rui Wang. (2009). Asymmetric Organocatalytic N‐Alkylation of Indole‐2‐carbaldehydes with α,β‐Unsaturated Aldehydes: One‐Pot Synthesis of Chiral Pyrrolo[1,2‐a]indole‐2‐carbaldehydes. Chemistry - A European Journal. 16(2). 440–444. 113 indexed citations
20.
Liu, Chunxia. (2004). Present development and prospect of hepatotoxic Chinese materia medica. Zhongcaoyao. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026